Cardiology Drugs

Company Preface To meet critical requirements of the Pharmaceutical industry, we, Alna Biotech, were established in 2007. Our company has established two separate divisions, namely, MEPFARMA and H I & Critical Care. Since our foundation, we have been exceeding clients expectations with our assortment of quality-assured products. As a symbol of our commitment to quality and continuous improvement process, we have based our quality system on the tenets of ISO 9001:2008 standard. Owing to our quality-centric business approach, we have carved a dominant presence across worldwide markets as one of the leading manufacturers, suppliers and service